Neurokinin 3 Receptor Antagonists Compared With Serotonin Norepinephrine Reuptake Inhibitors for Non-Hormonal Treatment of Menopausal Hot Flushes: A Systematic Qualitative Review

被引：0
|
作者：
Sara J. Menown
Javier A. Tello
机构：
[1] University of St Andrews,School of Medicine
[2] College of Medical,School of Medicine, Dentistry and Nursing
[3] Veterinary & Life Sciences,Biomedical Research Complex
[4] University of Glasgow,Centre for Biophotonics
[5] University of St Andrews,undefined
[6] University of St Andrews,undefined
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
Menopause; Vasomotor symptoms; Hot flushes/flashes; Neurokinin 3 receptor antagonist; Fezolinetant; Elinzanetant (NT-814); MLE4901; Serotonin Norepinephrine Reuptake Inhibitor; Venlafaxine; Desvenlafaxine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5025 / 5045
页数：20
相关论文
共 18 条
  • [1] Neurokinin 3 Receptor Antagonists Compared With Serotonin Norepinephrine Reuptake Inhibitors for Non-Hormonal Treatment of Menopausal Hot Flushes: A Systematic Qualitative Review
    Menown, Sara J.
    Tello, Javier A.
    ADVANCES IN THERAPY, 2021, 38 (10) : 5025 - 5045
  • [2] TREATMENT OF MENOPAUSAL HOT FLUSHES WITH VERALIPRIDE, A NON-HORMONAL AGENT
    MARZOLF, G
    EBERST, B
    AERTS, A
    LECORNU, C
    MARK, J
    GANDAR, R
    SEMAINE DES HOPITAUX, 1982, 58 (41): : 2382 - 2384
  • [3] Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy
    Hassan, Fatima
    Saleem, Anam
    Samuel, Sehar Saba
    Sarfraz, Zouina
    Sarfraz, Azza
    Sarfraz, Muzna
    Manish, K. C.
    MEDICINE, 2023, 102 (23) : E33978
  • [4] The Role of Neurokinin 3 Receptor Antagonists in the Management of Menopausal Hot Flushes
    Keogh, C.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2021, 61 : 9 - 9
  • [5] The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials
    Azizi, Marzieh
    Khani, Soghra
    Kamali, Mahsa
    Elyasi, Forouzan
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2022, 47 (03) : 173 - 193
  • [6] Neurokinin 3 Receptor Antagonism: A Novel Treatment for Menopausal Hot Flushes
    Modi, Manish
    Dhillo, Waljit S.
    NEUROENDOCRINOLOGY, 2019, 109 (03) : 242 - 248
  • [7] Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial
    Prague, Julia K.
    Roberts, Rachel E.
    Comninos, Alexander N.
    Clarke, Sophie
    Jayasena, Channa N.
    Nash, Zachary
    Doyle, Chedie
    Papadopoulou, Deborah A.
    Bloom, Stephen R.
    Mohideen, Pharis
    Panay, Nicholas
    Hunter, Myra S.
    Veldhuis, Johannes D.
    Webber, Lorraine C.
    Huson, Les
    Dhillo, Waljit S.
    LANCET, 2017, 389 (10081): : 1809 - 1820
  • [8] Incidence of adverse events and comparative tolerability of selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for the treatment of anxiety, obsessive-compulsive, and stress disorders: a systematic review and network meta-analysis
    Gosmann, Natan Pereira
    Costa, Marianna de Abreu
    Jaeger, Marianna de Barros
    Frozi, Julia
    Spanemberg, Lucas
    Manfro, Gisele Gus
    Cortese, Samuele
    Cuijpers, Pim
    Pine, Daniel Samuel
    Salum, Giovanni Abrahao
    PSYCHOLOGICAL MEDICINE, 2023, 53 (09) : 3783 - 3792
  • [9] Neurokinin 3 receptor antagonism is a highly effective, novel treatment for menopausal hot flushes with rapid onset: a phase 2, randomised, double-blind, placebo-controlled trial
    Prague, Julia K.
    Roberts, Rachel E.
    Comninos, Alexander N.
    Clarke, Sophie
    Jayasena, Channa N.
    Nash, Zachary
    Doyle, Chedie
    Papadopoulou, Deborah
    Bloom, Stephen R.
    Mohideen, Pharis
    Lin, Vivian
    Stern, Theresa
    Panay, Nicholas
    Hunter, Myra S.
    Veldhuis, Johannes D.
    Webber, Lorraine C.
    Huson, Les
    Dhillo, Waljit S.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2017, 24 (12): : 1429 - 1430
  • [10] NT-814, a Non-Hormonal Dual Neurokinin 1,3 Receptor Antagonist Markedly Improves Hot Flashes in Post-Menopausal Women; Results of a Randomised, Double-Blind, Placebo-Controlled Study
    Simon, James
    Anderson, Richard
    Ballantyne, Elizabeth
    Joffe, Hadine
    Kerr, Mary
    Lumsden, Mary Ann
    Panay, Nicholas
    Seymore, Susan
    Trower, Mike
    Pawsey, Stephen
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2020, 27 (12): : 1461 - 1461
12